Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AR › Fayetteville › NPI 1083609150
Hospital

Washington Regional Medical Center

Washington Regional Medical Center was paid $10.85M by Medicaid between Jan 2018 and Dec 2024, across 263 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 9.2% of everything it billed.

33Billing provider infoWASHINGTON REGIONAL MEDICAL CENTER
FAYETTEVILLE, AR 72703
33aNPI1083609150assigned 09/15/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.85M
24GClaims739,496
24DCodes billed263
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Arkansas

Rank by total paid#8 of 49
Median peer was paid$2.62M
This provider vs. median4.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201875,923$1.36M
201990,839$1.83M
2020110,555$1.09M
202189,204$1.56M
2022112,879$1.72M
2023156,163$1.90M
2024incomplete103,933$1.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
74177 Computed tomography, abdomen and pelvis; with contrast material 9.2% 8,033 6,682 $995K
70450 Computed tomography, head or brain; without contrast material 7.5% 9,594 7,852 $814K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.5% 6,554 5,354 $486K
87631 4.3% 7,149 5,999 $472K
80048 Basic metabolic panel (calcium, ionized) 3.8% 30,208 21,436 $415K
71275 Computed tomographic angiography, chest, with contrast material 3.6% 2,503 2,065 $387K
72125 Computed tomography, cervical spine; without contrast material 3.6% 3,727 3,109 $387K
80053 Comprehensive metabolic panel 3.2% 20,929 16,175 $344K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.9% 3,886 2,938 $318K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.7% 4,727 3,938 $292K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.6% 45,448 32,164 $285K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.3% 4,282 3,047 $250K
251 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.9% 16,036 $210K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.8% 1,551 $191K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.6% 6,722 $172K
99284 Emergency room visit (serious) 1.6% 5,082 $169K
99283 Emergency room visit (moderate) 1.5% 3,201 $167K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.5% 2,911 $167K
59025 Fetal non-stress test 1.3% 1,547 $143K
96361 Intravenous infusion, hydration; each additional hour 1.3% 10,254 $139K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 18,123 $139K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.2% 1,538 $133K
99285 Emergency room visit (most serious) 1.1% 4,920 $121K
84484 1.1% 16,870 $117K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.0% 825 $112K
86901 <1% 5,706 $107K
71045 Radiologic examination, chest; single view <1% 15,633 $106K
81025 <1% 13,443 $101K
80076 <1% 12,709 $93K
83690 <1% 14,160 $87K
83880 <1% 4,624 $84K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,545 $77K
70551 Magnetic resonance imaging, brain; without contrast material <1% 557 $77K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 388 $74K
70498 <1% 766 $67K
72131 <1% 672 $65K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,761 $64K
C1769 Guide wire <1% 2,479 $62K
70496 <1% 669 $62K
80320 <1% 4,332 $58K
82962 <1% 11,972 $55K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,496 $55K
82565 <1% 8,992 $54K
71046 Radiologic examination, chest; 2 views <1% 3,233 $52K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,781 $51K
87077 <1% 7,275 $51K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,386 $50K
85730 <1% 12,455 $48K
76801 <1% 1,302 $42K
84145 <1% 3,687 $41K
97162 <1% 1,131 $40K
80329 <1% 3,367 $40K
85610 <1% 14,039 $40K
81002 <1% 12,827 $39K
85027 <1% 8,073 $39K
93017 <1% 1,954 $37K
81001 <1% 10,176 $36K
87660 <1% 1,695 $35K
87480 <1% 1,698 $34K
87510 <1% 1,696 $34K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 831 $33K
97161 <1% 604 $33K
70486 <1% 282 $33K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,325 $32K
83735 <1% 7,395 $32K
96375 Therapeutic injection; each additional sequential IV push <1% 11,147 $30K
83605 <1% 4,056 $29K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 143 $29K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 829 $27K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 829 $27K
86850 <1% 4,248 $26K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 2,708 $26K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,408 $25K
87081 <1% 3,675 $25K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,313 $25K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 266 $25K
93458 <1% 285 $24K
J2785 Injection, regadenoson, 0.1 mg <1% 797 $24K
87186 <1% 4,896 $23K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 552 $23K
84702 <1% 2,264 $23K
87040 <1% 3,474 $23K
73562 <1% 991 $22K
82803 <1% 1,646 $22K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,583 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,287 $21K
87070 <1% 2,857 $21K
73630 <1% 1,035 $21K
84703 <1% 2,659 $20K
84132 <1% 3,065 $20K
93971 <1% 655 $20K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,087 $19K
36415 Collection of venous blood by venipuncture <1% 12,862 $18K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 594 $18K
85379 <1% 1,879 $17K
J3490 Unclassified drugs <1% 7,831 $17K
87581 <1% 421 $17K
87486 <1% 421 $17K
76830 Ultrasound, transvaginal <1% 331 $17K
87400 <1% 3,001 $17K
97001 <1% 329 $15K
73610 <1% 1,027 $15K
86900 <1% 5,765 $14K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 289 $14K
80050 General health panel <1% 361 $14K
84443 Thyroid stimulating hormone (TSH) <1% 2,769 $14K
73130 <1% 728 $13K
G0378 Hospital observation service, per hour <1% 1,033 $12K
73030 <1% 835 $12K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 1,920 $11K
94760 <1% 1,641 $10K
90715 <1% 506 $10K
87420 <1% 957 $10K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 4,696 $9K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 576 $9K
C1760 Closure device, vascular (implantable/insertable) <1% 172 $9K
36430 <1% 126 $9K
80061 Lipid panel <1% 863 $9K
82330 <1% 1,170 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 600 $8K
71020 <1% 935 $8K
84100 <1% 2,794 $8K
87205 <1% 2,625 $7K
96376 <1% 3,446 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 498 $7K
81003 <1% 2,676 $7K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 676 $6K
J1650 Injection, enoxaparin sodium, 10 mg <1% 749 $6K
85007 <1% 2,314 $6K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 482 $6K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,969 $6K
71250 <1% 65 $6K
85520 <1% 1,446 $5K
73110 <1% 309 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 8,071 $5K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 135 $4K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 44 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,215 $4K
85014 <1% 1,480 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 970 $4K
88720 <1% 651 $3K
86140 <1% 814 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 456 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 651 $3K
72128 <1% 29 $3K
77080 <1% 64 $3K
71010 <1% 608 $3K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 242 $3K
87075 <1% 567 $3K
97597 <1% 307 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 3,487 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 465 $2K
J1815 Injection, insulin, per 5 units <1% 1,016 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,100 $2K
82550 <1% 393 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 77 $2K
72100 <1% 122 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 9,575 $2K
94761 <1% 229 $2K
A9573 Injection, gadopiclenol, 1 ml <1% 97 $2K
36592 <1% 111 $2K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,048 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,528 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,340 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,090 $1K
84295 <1% 841 $1K
87088 <1% 164 $1K
73502 <1% 134 $1K
73080 <1% 103 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 264 $1K
85384 <1% 114 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,952 $1K
82010 <1% 136 $885.26
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,848 $875.83
84550 <1% 177 $827.79
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 15 $815.51
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,649 $784.84
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 135 $727.42
G0379 Direct admission of patient for hospital observation care <1% 2,667 $721.39
87045 <1% 84 $705.23
0001A <1% 18 $700.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 457 $685.58
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 678 $665.05
J2060 Injection, lorazepam, 2 mg <1% 296 $649.65
A9270 Non-covered item or service <1% 39,543 $644.02
J3370 Injection, vancomycin hcl, 500 mg <1% 956 $513.10
85652 <1% 268 $511.05
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,275 $499.47
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 752 $496.00
97165 <1% 22 $494.40
82570 <1% 102 $487.33
C1729 Catheter, drainage <1% 177 $455.63
87427 <1% 49 $403.60
97163 <1% 30 $395.52
74018 <1% 28 $385.45
73090 <1% 26 $370.00
J1245 Injection, dipyridamole, per 10 mg <1% 190 $359.45
99213 Doctor's office visit, returning patient (routine) <1% 626 $296.63
74022 <1% 13 $296.51
93970 <1% 15 $291.50
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 59 $244.20
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 46 $239.74
83986 <1% 47 $218.50
A6209 Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 201 $208.85
87147 <1% 42 $207.18
84156 <1% 45 $199.23
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 934 $197.10
87340 <1% 17 $195.73
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 336 $158.39
87046 <1% 67 $149.49
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 759 $144.80
J1790 Injection, droperidol, up to 5 mg <1% 147 $143.74
86923 <1% 38 $106.13
82728 <1% 18 $102.55
83550 <1% 19 $94.10
82247 <1% 14 $93.21
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 182 $88.79
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 214 $87.70
90653 <1% 17 $83.49
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,437 $72.39
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,374 $71.99
86592 <1% 14 $70.80
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 283 $66.40
76819 Fetal biophysical profile; without non-stress testing <1% 17 $63.01
82947 <1% 12 $61.60
85347 <1% 58 $58.64
84439 <1% 33 $51.52
83540 <1% 17 $48.75
A6211 Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing <1% 74 $46.98
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 127 $45.00
99214 Doctor's office visit, returning patient (more involved) <1% 266 $44.68
97535 Self-care/home management training, each 15 minutes <1% 399 $36.91
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 44 $34.80
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,078 $34.22
89051 <1% 17 $31.44
C1758 Catheter, ureteral <1% 178 $19.70
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 4,509 $17.80
J1171 Injection, hydromorphone, 0.1 mg <1% 76 $16.20
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 79 $15.78
G0008 Administration of influenza virus vaccine <1% 35 $15.45
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 172 $7.37
J1940 Injection, furosemide, up to 20 mg <1% 155 $7.34
85018 <1% 23 $6.76
J7510 Prednisolone oral, per 5 mg <1% 16 $1.80
91300 <1% 18 $0.10
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 26 $0.01
90662 0% 18 $0.00
97116 0% 681 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 38 $0.00
J7643 Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram 0% 87 $0.00
36600 0% 18 $0.00
P9016 Red blood cells, leukocytes reduced, each unit 0% 31 $0.00
L4387 Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf 0% 16 $0.00
82055 0% 12 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 14 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 0% 45 $0.00
J7999 Compounded drug, not otherwise classified 0% 305 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 99 $0.00
88304 0% 39 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 280 $0.00
A4217 Sterile water/saline, 500 ml 0% 17 $0.00
0352U 0% 18 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 75 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialECKELS, DAN (SR. VP & CFO)
Same official

Other billing entities under ECKELS, DAN

Full network →
ProviderLocationPaid
Washington Regional Medical CenterFayetteville, AR$1.17M
Washington Regional Medical SystemLincoln, AR$12K
Washington Regional Medical SystemFayetteville, AR$9K
Washington Regional Medical CenterFayetteville, AR$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.